Use of Innovative Technologies in Development of Drugs, Vaccines and Diagnostic Modalities

Comment on this policy The AVMA supports and encourages the ethical use of innovative technologies in veterinary medicine to develop new or improved biologics, therapeutic agents and diagnostic modalities. Such use may include but is not limited to:
  • Internationally harmonized research, development, production, licensure/approval, sale, distribution, and use of safe and effective vaccines, pharmaceuticals, delivery systems and other therapeutic products used in animal health.
  • Science-based regulatory policies and procedures supporting pre and post-approval product evaluations.
  • Development of innovative, useful (sensitive, specific, and robust) diagnostic and surveillance tools.

Related AVMA Policy:

Background: